Medifast earnings were $3.6M for the trailing 12 months ending Jun 30, 2025, with -87.7% growth year over year. The latest MED earnings report on Jun 30, 2025 announced Q2 2025 earnings of $2.5M, down 421.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MED reported annual earnings of $2.1M, with -97.9% growth.
MED past earnings growth
How has MED's earnings growth performed historically?
On MED's earnings call on Invalid Date, Medifast (NYSE: MED) reported Q2 2025 earnings per share (EPS) of $0.23, up 130.67% year over year. Total MED earnings for the quarter were $2.48 million. In the same quarter last year, Medifast's earnings per share (EPS) was -$0.75.
As of the last Medifast earnings report, Medifast is currently profitable. Medifast's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $3.64 million, a 87.6% decrease year over year.
What was MED's earnings growth in the past year?
As of Medifast's earnings date in Invalid Date, Medifast's earnings has grown -87.69% year over year. This is 104.31 percentage points lower than the US Personal Services industry earnings growth rate of 16.62%. MED earnings in the past year totalled $3.64 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.